Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

NCT03452527 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped Business Reasons

Conditions

Choroidal Neovascularization
Wet Macular Degeneration

Interventions

BIOLOGICAL: ICON-1
BIOLOGICAL: aflibercept

Sponsor

Iconic Therapeutics, Inc.